Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Developing TRAIL/TRAIL death receptor-based cancer therapies
HTML
Details
Locations
Year:
2018
Type:
review
Source:
Cancer and Metastasis Reviews
DOI:
10.1007/s10555-018-9728-y
Authors:
Xun Yuan,
Ambikai Gajan,
Qian Chu,
Hua Xiong,
Kongming Wu,
Gen Sheng Wu
show all 6
Institutions:
Wayne State University,
The Barbara Ann Karmanos Cancer Institute,
Tongji Hospital,
Huazhong University of Science and Technology
Language:
English
Topic:
Cell death mechanisms and regulation
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
TRAIL,
death receptor 4,
DR5,
TRAIL receptor agonists,
TNF superfamily
SDG:
Good health and well-being
Open Access status:
green
Funders:
National Natural Science Foundation of China,
National Institutes of Health,
National Cancer Institute
Awards:
Developing targeted therapies for triple-negative breast cancer,
G7635178612
OpenAlex ID:
W2789657762
FWCI:
1.988
Cites:
164
Cited by:
271
Related to:
10